Isolation of CD34(+) cells with the Amgen cell selection system provides T, NK and tumor cell depletion of peripheral blood stem cells from breast cancer patients.

被引:0
|
作者
Symann, M
Guillaume, T
Salmon, M
Briddell, R
Zilm, K
Canon, JL
Andre, M
Jurdan, M
Johnsen, H
Richel, D
Myltenyi, S
Ewen, C
McNiece, I
机构
[1] HOP ST LUC,BRUSSELS,BELGIUM
[2] HERLEV HOSP,COPENHAGEN,DENMARK
[3] MST,ENSCHEDE,NETHERLANDS
[4] AMGEN INC,THOUSAND OAKS,CA
[5] AMCELL,SUNNYVALE,CA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:254 / 254
页数:1
相关论文
共 50 条
  • [21] CD34 positive selection of peripheral blood stem cells for haploidentical transplantation using the SuperMACS and CliniMACS system
    Köhler, A
    Müller, A
    Fuchs, D
    Zintl, F
    BLOOD, 1998, 92 (10) : 447A - 447A
  • [22] Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer
    Theodoropoulos, Panayiotis A.
    Polioudaki, Hara
    Agelaki, Sofia
    Kallergi, Galatea
    Saridaki, Zacharenia
    Mavroudis, Dimitris
    Georgoulias, Vassilis
    CANCER LETTERS, 2010, 288 (01) : 99 - 106
  • [23] CD34 positive blood cells for allogeneic progenitor and stem cell transplantation
    Link, H
    Arseniev, L
    LEUKEMIA & LYMPHOMA, 1997, 26 (5-6) : 451 - 465
  • [24] Autologous stem cell transplantation with positive selection of CD34 cells for angioimmunoblastic T-cell lymphoma.
    de Paz, R
    Canales, MA
    Arrieta, R
    Cobo, T
    Hernandez, D
    Hernandez-Navarro, F
    BLOOD, 2003, 102 (11) : 486B - 486B
  • [25] Combining positive and negative cell selection improves T cell depletion of peripheral blood stem cells.
    Tabilio, A
    Falzetti, F
    Aversa, F
    Jacucci, R
    Zei, T
    Covalovo, S
    Martelli, MF
    BONE MARROW TRANSPLANTATION, 1998, 21 : S20 - S20
  • [26] T-cell depletion of allogeneic peripheral blood stem cells
    Link, H
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 1999, 12 (1-2) : 87 - 98
  • [27] Cd34+ cell transplantation from mobilized peripheral blood by immunomagnetic adsorption in breast cancer patients.
    Cancelas, JA
    Canals, C
    Querol, S
    Picon, M
    Azqueta, C
    Sola, C
    Montes, A
    Griera, E
    Lloveras, B
    Lopez, JJ
    Germa, J
    Amill, B
    Torrico, C
    Fabra, A
    Garcia, J
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 121 - 121
  • [28] CD34(+) cell selection using the Isolex 300i magnetic cell separation system for stage IV breast cancer patients.
    Ahmed, T
    Lake, D
    Koncherla, R
    Feldman, E
    Seiter, K
    Grima, K
    Preti, R
    BLOOD, 1996, 88 (10) : 3710 - 3710
  • [29] Stem cell component therapy: Supplementation of unmanipulated marrow with CD34 enriched peripheral blood stem cells.
    Burt, RK
    Villa, M
    Fishman, M
    Brush, M
    Rosen, S
    Traynor, A
    BLOOD, 1998, 92 (10) : 140A - 140A
  • [30] STUDY TO ASSESS THE CORRELATION OF PREDICTIVE COUNT OF CD34 CELLS IN THE BLOOD TO THE YIELD IN PERIPHERAL BLOOD STEM CELL HARVEST
    Choudhuri, S.
    Bloor, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 492 - 492